Yellow Card biobank is a collaboration between the MHRA and Genomics England. Its goal is to improve understanding of how a patient’s genetic makeup may increase their risk of harm from side effects. They are collecting your data but not presenting the methods to be used to correlate drug side effects with people’s genetic makeup.
